Related Experiment Video
Updated: Jan 16, 2026

13:43
A Robust Single-Particle Cryo-Electron Microscopy cryo-EM Processing Workflow with cryoSPARC, RELION, and Scipion
Published on: January 31, 2022
15.0K
Disulfide-constrained Fabs overcome target size limitation for high-resolution single particle cryoEM
Jennifer E Kung1,2, Matthew C Johnson1, Dimitry Tegunov1
1Department of Structural Biology, Genentech Inc., South San Francisco, CA, USA.
Nature Communications
|September 30, 2025
Summary
We developed Rigid Fabs, engineered antibody fragments, to enable high-resolution cryo-electron microscopy (cryoEM) of small proteins. This breakthrough overcomes size limitations for studying disease-related targets.
Area of Science:
- Structural Biology
- Biochemistry
- Biophysics
Background:
- High-resolution protein structures are crucial for biological understanding and drug development.
- Single-particle cryo-electron microscopy (cryoEM) excels for large complexes but struggles with small proteins (<50 kDa) due to low signal-to-noise and alignment challenges.
- Existing methods using scaffold proteins to increase target size often introduce flexibility, hindering high-resolution structure determination.
Purpose of the Study:
- To develop a novel strategy for determining high-resolution structures of small proteins using cryoEM.
- To engineer antibody fragments (Fabs) into conformationally stable entities suitable for cryoEM analysis of small targets.
- To demonstrate the efficacy of this approach for resolving biologically relevant small proteins.
Main Methods:
- Iterative engineering of antibody fragments (Fabs) to create conformationally Rigid Fabs.
- Introduction of strategic disulfide bonds within Fabs to enhance structural rigidity and stability.
- Application of Rigid Fabs in single-particle cryoEM for structure determination of small proteins.
Main Results:
- Successfully transformed Fabs into Rigid Fabs, characterized by enhanced conformational stability.
- Achieved high-resolution cryoEM structures (2.3–2.5 Å) for two small proteins: Angiopoietin-2 (Ang2, 26 kDa) and KRAS (21 kDa).
- Demonstrated the general applicability of Rigid Fabs across different species, frameworks, and chimeric constructs.
Conclusions:
- The disulfide-constrained Rigid Fab strategy provides a robust solution for overcoming the size limitations of small proteins in cryoEM.
- This method enables high-resolution structural studies of previously challenging small, disease-related proteins.
- Offers a versatile approach for advancing structural biology and drug discovery for small protein targets.

